Phase I, Combining Oral Topotecan With Oral Pazopanib
| Status: | Archived |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | September 2008 |
| End Date: | August 2012 |
A Phase I Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Two Schedules of Oral Topotecan in Combination With Pazopanib in Subjects With Advanced Solid Tumors
To determined what dose of topotecan can be safely given with daily pazopanib.
A Phase I Open-label Study of the Safety, Tolerability, and Pharmacokinetics of Two
Schedules of Oral Topotecan in combination with Pazopanib in Subjects with Advanced Solid
Tumors
We found this trial at
1
site
Click here to add this to my saved trials
